TP53 and neoplasm: However, some evidence suggests that p53 wild-type tumour cell lines carrying heterozygous gain-of-function mutations in the p53-phosphatase WIP1 (PPM1D) are defective for G1 arrest through the mitotic timer pathway (Meitinger et al, 2024).